Imago BioSciences, Inc. - Common stock (NQ:IMGO)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Imago BioSciences, Inc. - Common stock

< Previous 1 2 3 Next >

45 Stocks Moving In Tuesday's Mid-Day Session ↗

September 07, 2021

Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...

Via Benzinga

Imago BioSciences Reports Second Quarter 2021 Financial Results and Provides Recent Business Updates

August 19, 2021

From Imago BioSciences, Inc.

Via Business Wire

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

Imago BioSciences Receives Orphan Designation From European Medicines Agency for Bomedemstat for the Treatment of Essential Thrombocythemia

July 30, 2021

From Imago BioSciences

Via Business Wire

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

61 Biggest Movers From Yesterday ↗

August 03, 2021

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program....

Via Benzinga

Imago BioSciences, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares

July 26, 2021

From Imago BioSciences, Inc.

Via Business Wire

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering

July 20, 2021

From Imago BioSciences, Inc.

Via Business Wire

Opening Day: Wahlberg-backed Gym Owner F45 Opens Higher In Public Debut ↗

July 18, 2021

Mark Wahlberg-backed F45 Training rose as much as 11% in its trading debut but fell near the offer price after its $325M IPO on Thursday. The listing was delayed by the COVID-19 pandemic and then...

Via Talk Markets

Topics Initial Public Offering

Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

July 15, 2021

From Imago BioSciences, Inc.

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.